In vivo toxicological evaluation of 3-benzylideneindolin-2-one: antifungal activity against clinical isolates of dermatophytes
Sign Up to like & getrecommendations! Published in 2025 at "BMC Pharmacology & Toxicology"
DOI: 10.1186/s40360-025-00850-1
Abstract: Dermatophytes, the primary causative agents of superficial cutaneous fungal infections in humans, present a significant therapeutic challenge owing to the increasing prevalence of recurrent infections and the emergence of antifungal resistance. To address this critical… read more here.
Keywords: clinical isolates; benzylideneindolin one; vivo toxicological; antifungal activity ... See more keywords